tirzepatide and heart disease glp-1 Bridging the gap between GLP1-receptor agonists cardiovascular outcomes: evidence for the role of Association of Tirzepatide Use With

The improvements in social behavior were accompanied by increased oxytocin receptor expression in the anterior cingulate cortex

This allows you to pay less out-of-pocket for the medication, making it more affordable

They were initially developed and approved for type 2 diabetes

This gradual titration helps minimize gastrointestinal side effects commonly associated with incretin-based therapies

Concerns about muscle loss while on GLP-1s are real, so its important to talk with a healthcare provider about your eating and exercise plan to make sure that even as youre losing weight you continue to get adequate nutrition (focusing on protein and nutrient dense foods) and stave off muscle loss

These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease